METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets Hard-to-Treat esophageal cancer
Disease control OngoingThis early-stage trial tested a drug called adavosertib together with radiation therapy for people with advanced esophageal or stomach cancer that cannot be surgically removed. The goal was to find the safest dose and see how well the combination works. Only 4 people took part, s…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells target brain tumors in new trial
Disease control OngoingThis early-stage trial tests a treatment called HER2-CAR T cells for people with HER2-positive cancers that have spread to the brain or its lining. The cells are given directly into the brain's fluid spaces to try to kill tumor cells. The main goals are to find the safest dose an…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC